Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Georges

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Cancer Genomics & Proteomics|April 9, 2014
Proteases as activators for cytotoxic prodrugs in antitumor therapyUlrich H Weidle, Georg Tiefenthaler, Guy Georges
Cancer Genomics & Proteomics|May 18, 2012
Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizonUlrich H Weidle, Guy Georges, Ulrich Brinkmann
Cancer Genomics & Proteomics|November 26, 2014
TCR-MHC/peptide interaction: prospects for new anti-tumoral agentsUlrich H Weidle, Guy Georges, Georg Tiefenthaler
Cancer Genomics & Proteomics|November 20, 2012
Genetically engineered fusion proteins for treatment of cancerUlrich H Weidle, Britta Schneider, Guy Georges, et al.
Bioinformatics (Oxford, England)|January 31, 2022
ABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimationBrennan Abanades, Guy Georges, Alexander Bujotzek, et al.
Proteins|January 11, 2018
Antibody side chain conformations are position-dependentJinwoo Leem, Guy Georges, Jiye Shi, et al.
Proteins|March 26, 2017
The H3 loop of antibodies shows unique structural characteristicsCristian Regep, Guy Georges, Jiye Shi, et al.
Mabs|July 9, 2016
ABodyBuilder: Automated antibody structure prediction with data-driven accuracy estimationJinwoo Leem, James Dunbar, Guy Georges, et al.
Cancer Genomics & Proteomics|July 30, 2013
The emerging role of new protein scaffold-based agents for treatment of cancerUlrich H Weidle, Johannes Auer, Ulrich Brinkmann, et al.
Mabs|June 1, 2019
CDR-H3 loop ensemble in solution - conformational selection upon antibody bindingMonica L Fernández-Quintero, Johannes Kraml, Guy Georges, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Cancer Genomics & Proteomics|April 9, 2014
Proteases as activators for cytotoxic prodrugs in antitumor therapyUlrich H Weidle, Georg Tiefenthaler, Guy Georges
Cancer Genomics & Proteomics|May 18, 2012
Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizonUlrich H Weidle, Guy Georges, Ulrich Brinkmann
Cancer Genomics & Proteomics|November 26, 2014
TCR-MHC/peptide interaction: prospects for new anti-tumoral agentsUlrich H Weidle, Guy Georges, Georg Tiefenthaler
Cancer Genomics & Proteomics|November 20, 2012
Genetically engineered fusion proteins for treatment of cancerUlrich H Weidle, Britta Schneider, Guy Georges, et al.
Bioinformatics (Oxford, England)|January 31, 2022
ABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimationBrennan Abanades, Guy Georges, Alexander Bujotzek, et al.
Proteins|January 11, 2018
Antibody side chain conformations are position-dependentJinwoo Leem, Guy Georges, Jiye Shi, et al.
Proteins|March 26, 2017
The H3 loop of antibodies shows unique structural characteristicsCristian Regep, Guy Georges, Jiye Shi, et al.
Mabs|July 9, 2016
ABodyBuilder: Automated antibody structure prediction with data-driven accuracy estimationJinwoo Leem, James Dunbar, Guy Georges, et al.
Cancer Genomics & Proteomics|July 30, 2013
The emerging role of new protein scaffold-based agents for treatment of cancerUlrich H Weidle, Johannes Auer, Ulrich Brinkmann, et al.
Mabs|June 1, 2019
CDR-H3 loop ensemble in solution - conformational selection upon antibody bindingMonica L Fernández-Quintero, Johannes Kraml, Guy Georges, et al.
Pageof 7